Back
Cimpress PLC 10K Form
Buy
63
CMPR
Cimpress PLC
Last Price:
79.17
Seasonality Move:
13.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | CMPR/Cimpress PLC Quarterly |
| 2023-04-27 | 10Q | CMPR/Cimpress PLC Quarterly |
| 2023-01-26 | 10Q | CMPR/Cimpress PLC Quarterly |
| 2022-10-27 | 10Q | CMPR/Cimpress PLC Quarterly |
| 2022-04-28 | 10Q | CMPR/Cimpress PLC Quarterly |
| 2022-01-27 | 10Q | CMPR/Cimpress PLC Quarterly |
Receive CMPR News And Ratings
See the #1 stock for the next 7 days that we like better than CMPR
CMPR Financial Statistics
Sales & Book Value
| Annual Sales: | $3.29B |
|---|---|
| Cash Flow: | $-27.19M |
| Price / Cash Flow: | 10.47 |
| Annual Sales: | $-22.60 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 5.76000 |
|---|---|
| Net Income (TTM): | $156.58M |
| Gross Margin: | $1.6B |
| Return on Equity: | 0% |
| Return on Assets: | 8.4% |
Cimpress PLC Earnings Forecast
Key Cimpress PLC Financial Ratios
- The Gross Profit Margin over the past 24 years for CMPR is 48.51%.
- The Selling, General & Administrative Expenses for CMPR have been equal to 30.24% of Gross Profit Margin.
- The Research & Development expenses have been 9.78% of Revenue.
- The Interest Expense is 68.99% of Operating Income.
- The Net Earning history of CMPR is 5.28% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 15 years.
Cimpress PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | CMPR |
| CUSIP: | N20146 |
| Website: | cimpress.com |
Debt
| Debt-to-Equity Ratio: | -2.8 |
|---|---|
| Current Ratio: | 0.64 |
| Quick Ratio: | 0.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.7 |
|---|---|
| Forward P/E Ratio: | 0 |
CMPR Technical Analysis vs Fundamental Analysis
Buy
63
Cimpress PLC (CMPR)
is a Buy
Is Cimpress PLC a Buy or a Sell?
-
Cimpress PLC stock is rated a Buy
The current Cimpress PLC [CMPR] share price is $81.69. The Score for CMPR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.